Anúncio
Anúncio

DNA

DNA logo

Ginkgo Bioworks Holdings, Inc.

9.29
USD
Patrocinado
+0.22
+2.48%
09 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

9.32

+0.04
+0.38%

Relatórios de Lucros DNA

Rácio de surpresa positiva

DNA separação 6 de 17 últimas estimativas.

35%

Próximo Relatório

Data do Próximo Relatório
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/
--
Mudanças implicadas de Q-- -1 (Revenue/ EPS)
--
/
--

Ginkgo Bioworks Holdings, Inc. earnings per share and revenue

On 06 de nov. de 2025, DNA reported earnings of -1.45 USD per share (EPS) for Q3 25, missing the estimate of -1.25 USD, resulting in a -15.78% surprise. Revenue reached 38.84 milhão, compared to an expected 39.24 milhão, with a -1.02% difference. The market reacted with a -20.80% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analistas forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q3 2025, Ginkgo Bioworks Holdings, Inc. reported EPS of -$1.45, missing estimates by -15.78%, and revenue of $38.84M, -1.02% below expectations.
The stock price moved down -20.8%, changed from $11.30 before the earnings release to $8.95 the day after.
The next earning report is scheduled for --.
Based on -- analistas, Ginkgo Bioworks Holdings, Inc. is expected to report EPS of -- and revenue of -- for Q-- --.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio